Your browser doesn't support javascript.
loading
SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study.
Safarnezhad Tameshkel, Fahimeh; Abedin Dargoush, Shabnam; Amirkalali, Bahareh; Javadi, Saeedeh; Ghiaseddin, Ali; Alimohamadi, Yousef; Basi, Ali; Jamshidi Makiani, Mahin; Zamani, Farhad; Karbalaie Niya, Mohammad Hadi.
  • Safarnezhad Tameshkel F; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Abedin Dargoush S; Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
  • Amirkalali B; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Javadi S; Department of Internal Medicine, School of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Ghiaseddin A; Department of Chemistry, Michigan State University, East Lansing, MI, United States.
  • Alimohamadi Y; Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Basi A; Department of Hematology and Oncology, School of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Jamshidi Makiani M; Antimicrobial Resistant Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Zamani F; Department of Infectious Disease, School of Medicine, Firoozgar General Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Karbalaie Niya MH; Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
Front Med (Lausanne) ; 9: 1095194, 2022.
Article en En | MEDLINE | ID: mdl-36743671

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Año: 2022 Tipo del documento: Article